TOOKER ADIN M 4

Accession 0001225208-25-002053

CIK 0000874766other

View on SEC.gov Company Profile

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:05 PM ET

Size

31.8 KB

Accession

0001225208-25-002053

Insider Transaction Report

Form 4

Period: 2025-02-18

HARTFORD INSURANCE GROUP, INC.HIG

TOOKER ADIN M

President

Transactions

Exercise/Conversion
Common Stock
2025-02-18+10,996.794→ 36,817.067 total
Exercise/Conversion
Common Stock
2025-02-18$43.59/sh+6,864$299,202→ 43,681.067 total
Exercise/Conversion
Common Stock
2025-02-18$48.89/sh+6,732$329,127→ 50,413.067 total
Sale
Common Stock
2025-02-18$112.97/sh−200$22,595→ 50,213.067 total
Sale
Common Stock
2025-02-18$112.58/sh−6,664$750,244→ 43,549.067 total
Sale
Common Stock
2025-02-18$112.61/sh−6,732$758,073→ 36,817.067 total
Award
Performance Shares
2025-02-18+10,996.794→ 10,996.794 total
→ Common Stock (10,996.794 underlying)
Exercise/Conversion
Performance Shares
2025-02-18−10,996.794→ 0 total
→ Common Stock (10,996.794 underlying)
Exercise/Conversion
Stock Option
2025-02-18−6,732→ 13,462 total
Exercise: $48.89Exp: 2027-02-28→ Common Stock (6,732 underlying)
Exercise/Conversion
Stock Option
2025-02-18−6,864→ 6,864 total
Exercise: $43.59Exp: 2026-03-01→ Common Stock (6,864 underlying)

Holdings

Stock Option
Exercise: $49.01Exp: 2029-02-26→ Common Stock (26,687 underlying)
26,687
Stock Option
Exercise: $51.87Exp: 2031-02-23→ Common Stock (25,202 underlying)
25,202
Stock Option
Exercise: $53.81Exp: 2028-02-27→ Common Stock (24,922 underlying)
24,922
Stock Option
Exercise: $55.27Exp: 2030-02-25→ Common Stock (24,094 underlying)
24,094
Stock Option
Exercise: $69.41Exp: 2032-02-23→ Common Stock (24,155 underlying)
24,155
Stock Option
Exercise: $78.28Exp: 2033-02-28→ Common Stock (24,301 underlying)
24,301
Stock Option
Exercise: $95.74Exp: 2034-02-27→ Common Stock (16,492 underlying)
16,492

Footnotes (14)

[F1]On February 18, 2025, the Company's Compensation and Management Development Committee certified a performance share payout based on the level of the Company's performance relative to pre-established objectives for the January 1, 2022 through December 31, 2024 performance period. The performance shares were paid in shares of the Company's common stock.
[F10]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
[F11]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
[F12]One-third of the options became exercisable on February 23, 2023, an additional one-third of the options became exercisable on February 23, 2024 and the remaining one-third of the options will become exercisable on February 23, 2025, the third anniversary of the grant date.
[F13]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options will become exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
[F14]One-third of the options will become exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
[F2]The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 14, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
[F3]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $112.97-$112.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F4]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $111.91-$112.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F5]Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $112.10-$112.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F6]The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.
[F7]The options became fully exercisable on March 1, 2019, the third anniversary of the grant date.
[F8]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
[F9]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.

Documents

1 file

4
doc4.xmlPrimary

Issuer

HARTFORD INSURANCE GROUP, INC.

CIK 0000874766

→

Entity typeother

Related Parties

filerCIK 0001953211

Filing Metadata

Form type: 4
Filed: Feb 19, 7:00 PM ET
Accepted: Feb 20, 4:05 PM ET
Size: 31.8 KB

View on SEC.gov